Contact Information
37 Westminster Buildings, Theatre Square,
Nottingham, NG1 6LG
Clorox Warns of Accruing Costs From Cyberattack
The attack came amid a $500 million digital overhaul at the consumer products maker. Source link
iPhone 15 Pro Owners Complain About Overheating Problems
The issue threatens Apple’s premium phones, a cash cow essential to its growth and profits. Source link
iPhone 15 and 15 Pro First Look: Why a Tiny USB-C Port Is a Huge Deal
Apple’s latest may have new cameras, action buttons and designs, but that new port will have a bigger impact on buyers—and their cord collections. Source
China Evergrande Seeks U.S. Court Approval for $19 Billion Debt Restructuring
China Evergrande Group is seeking a U.S. court’s approval to restructure more than $19 billion in the company’s offshore debts, as the embattled property developer
Hawaiian Electric Is in Talks With Restructuring Firms
The utility is facing mounting litigation alleging it was negligent before and during the Maui wildfires. Source link
AMC Can Sell Nearly 400 Million New Shares Following Court Approval
Distressed movie-theater chain overcame opposition from meme investors concerned about dilution, winning court approval for transactions to sell more shares. Source link
WeWork Taps Directors With Bankruptcy Chops After Board Resignations
WeWork has brought in a slate of new board members experienced in restructuring troubled companies through bankruptcy to succeed three directors who resigned because of
WeWork Raises Doubt About Its Survival
WeWork on Tuesday raised doubt about its ability to stay in business as the co-working space provider faces losses and a dwindling cash pile amid
Efforts to Spotlight Private Equity's Healthcare Stakes Struggle for Traction
Congress and regulatory agencies have made scant headway in requiring medical companies to reveal owners. Source link
Venture Capitalist Seeks to Spur Drug Development for Rare Autoimmune Disease
Venture capitalist Luke Evnin has financed several successful biotechnology startups that develop treatments for cancer. Now he is encouraging drugmakers to tackle another disease: a rare autoimmune condition that